News & publications > News > Atlantis Healthcare Wins Two Prestigious Pharmaceutical Market Excellence Awards (PMEA)

Atlantis Healthcare Wins Two Prestigious Pharmaceutical Market Excellence Awards (PMEA)

Saturday, 18 November 2017
 
Atlantis Healthcare took home two awards this week at PMEA 2017!

Our ‘On Path’ program, developed with Amgen, was a winner in two categories:

• Excellence in Patient Education and Support
• Excellence in Marketing New Products

Matthew Walls, Chairman and CEO of Atlantis Healthcare said: "We are delighted to have won both the ‘Excellence in Patient Education and Support’ and ‘Excellence in Marketing New Products’ awards for the On Path program.   
 
“Winning these prestigious awards is wonderful recognition of our unique approach to patient support programs that deliver genuine behavior change, including increasing medicine adherence. We are very proud that the judges recognized the impact of the program in supporting patients to better self-manage their condition”.

In addition to winning the ‘Excellence in Patient Education and Support’ and ‘Excellence in Marketing New Products’ awards, Atlantis Healthcare’s On Path program was also shortlisted as a finalist for the ‘Excellence in Creating Value Beyond the Product’ award.  

See the full list of winners here
 

About Atlantis Healthcare Group

Atlantis Healthcare leverages health psychology to develop and deliver uniquely personalized healthcare solutions that drive sustained improvement in patient outcome through self-management and treatment adherence across chronic diseases.

With the largest team of globally recognized health psychology experts in a commercial setting, supported by digital creative experts, Atlantis Healthcare uses clinically proven models and academic research to develop award-winning behavior change programs, helping patients achieve better health outcomes. The group provides solutions and services across the globe from offices in UK, Germany, Spain, US, Australia and New Zealand.